Polycystic Kidney Diseases - 25 Studies Found Completed : A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002] : Autosomal Dominant Polycystic Kidney Disease : 2009-11-27 : Drug: OPC-41061 Repeated oral administration at doses of 15 mg twice daily (morning and evening) Not yet recruiting : The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain : Autosomal Dominant Polycystic Kidney Disease : 2016-04-08 : Device: Vessix Renal denervation using radio-ablation Terminated : Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease : Polycystic Kidney : 2008-11-25 : Drug: tripterygium wilfordii T Recruiting : Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease) : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2016-09-15 : Drug: Tolvaptan Recruiting : Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2014-04-14 : Drug: Triptolide-Containing Formulation <<< Previous